Breaking News Instant updates and real-time market news.

BLCM

Bellicum Pharmaceuticals

$6.85

0.1 (1.48%)

07:59
04/12/18
04/12
07:59
04/12/18
07:59

Bellicum price target raised to $18 from $10 at Cantor Fitzgerald

Cantor Fitzgerald analyst Elemer Piros raised his price target for Bellicum Pharmaceuticals to $18 following the announcement of the FDA's lift of its U.S. clinical hold for BPX-501. The analyst now has increased confidence across the BPX-501 platform. He reiterates an Overweight rating on the shares.

BLCM Bellicum Pharmaceuticals
$6.85

0.1 (1.48%)

02/26/18
JEFF
02/26/18
NO CHANGE
Target $16
JEFF
Buy
Bellicum should solve clinical hold within two months, says Jefferies
After hosting an investor meeting with Bellicum Pharmaceuticals management, Jefferies analyst Biren Amin thinks the FDA hold on BPX-501 should be solved in one to two months. To provide more details to FDA, Bellicum performed safety analysis in a database of BPX-501 and screened all patients for encephalopathy events, Amin tells investors in a research note. Seven cases were found in 241 treated patients, resulting a 2.9% incidence rate, which is at the lower end of the background rate associated with allo-transplant, the analyst points out. Amin points out that based on its analysis, management believes BPX-501 associated encephalopathy events show no similarities with acute and detrimental CD19-CART therapy related neurotoxicity. Bellicum expects to provide a full response to FDA in March, the analyst notes. Amin keeps a Buy rating on the shares with a $16 price target.
03/14/18
JEFF
03/14/18
NO CHANGE
Target $16
JEFF
Buy
Bellicum clinical hold should lift soon, says Jefferies
Jefferies analyst Biren Amin says Bellicum Pharmaceuticals last night provided an update of its leading prgm BPX-501 with an "encouraging" survival rate at one year in pediatric acute myeloid leukemia patients. For BPX-601, management reported CART cell expansion in one pancreatic cancer patient following rimiducid administration, providing first patient validation of the company's activation switch, Amin tells investors in a post-earnings research note. The analyst notes Bellicum has also responded to FDA including proposed protocol changes. Amin believes the clinical hold should lift soon and keeps a Buy rating on Bellicum Pharmaceuticals with a $16 price target.
04/11/18
WELS
04/11/18
UPGRADE
WELS
Outperform
Bellicum Pharmaceuticals upgraded to Outperform at Wells Fargo
04/12/18
WELS
04/12/18
UPGRADE
Target $23
WELS
Outperform
Wells Fargo upgrades Bellicum to Outperform on lifting of clinical hold
Wells Fargo analyst Jim Birchenough last night upgraded Bellicum Pharmaceuticals to Outperform from Market Perform and raised his price target for the shares to $23 from $6. The shares in premarket trading are up 27% to $8.70 following news that the FDA lifted the clinical hold on studies of BPX-501 in the U.S. Rapid resolution of the clinical hold "substantially de-risks the investment," Birchenough tells investors in a research note. He believes Bellicum's platform for controllable cell therapies is well positioned for therapeutic oncology indications.

TODAY'S FREE FLY STORIES

EBAY

eBay

$40.98

-0.2 (-0.49%)

05:09
04/26/18
04/26
05:09
04/26/18
05:09
Recommendations
eBay analyst commentary  »

eBay GMV growth…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TRVG

Trivago

$4.71

-1.65 (-25.94%)

05:01
04/26/18
04/26
05:01
04/26/18
05:01
Downgrade
Trivago rating change  »

Trivago downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

HPR

HighPoint Resources

$6.65

0.14 (2.15%)

04:58
04/26/18
04/26
04:58
04/26/18
04:58
Initiation
HighPoint Resources initiated  »

HighPoint Resources…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    May

AVY

Avery Dennison

$106.68

1.195 (1.13%)

04:57
04/26/18
04/26
04:57
04/26/18
04:57
Upgrade
Avery Dennison rating change  »

Avery Dennison upgraded…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Apr

04:55
04/26/18
04/26
04:55
04/26/18
04:55
General news
Jobless Claims to be reported at 08:30 »

Week of 4/21 Jobless…

04:55
04/26/18
04/26
04:55
04/26/18
04:55
General news
Breaking General news story  »

Week of 4/25 Fed Balance…

04:55
04/26/18
04/26
04:55
04/26/18
04:55
General news
Durable Goods Orders to be reported at 08:30 »

March Durable Goods…

04:55
04/26/18
04/26
04:55
04/26/18
04:55
General news
Durable Goods Orders Ex-transportation to be reported at 08:30 »

March Durable Goods…

WYN

Wyndham

$117.67

1.83 (1.58%)

, LQ

La Quinta

$19.70

0.08 (0.41%)

04:55
04/26/18
04/26
04:55
04/26/18
04:55
Conference/Events
La Quinta to host special shareholder meeting »

Special Shareholder…

WYN

Wyndham

$117.67

1.83 (1.58%)

LQ

La Quinta

$19.70

0.08 (0.41%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Apr

  • 02

    May

04:55
04/26/18
04/26
04:55
04/26/18
04:55
General news
Breaking General news story  »

6-Month Bill Announcement…

04:55
04/26/18
04/26
04:55
04/26/18
04:55
General news
Breaking General news story  »

Week of 4/16 Money Supply…

04:55
04/26/18
04/26
04:55
04/26/18
04:55
General news
International Trade in Goods Balance to be reported at 08:30 »

March International Trade…

04:55
04/26/18
04/26
04:55
04/26/18
04:55
General news
Wholesale Inventories [Advance] M/M % hange to be reported at 08:30 »

March Wholesale…

04:55
04/26/18
04/26
04:55
04/26/18
04:55
General news
Breaking General news story  »

Week of 4/20 EIA Natural…

SMMT

Summit Therapeutics

$13.66

0.13 (0.96%)

04:55
04/26/18
04/26
04:55
04/26/18
04:55
Conference/Events
Summit Therapeutics management to meet with Needham »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Apr

  • 03

    May

ABBV

AbbVie

$91.91

0.57 (0.62%)

, ACOR

Acorda Therapeutics

$22.95

-0.15 (-0.65%)

04:55
04/26/18
04/26
04:55
04/26/18
04:55
Conference/Events
American Academy of Neurology to hold annual meeting »

2018 Annual Meeting of…

ABBV

AbbVie

$91.91

0.57 (0.62%)

ACOR

Acorda Therapeutics

$22.95

-0.15 (-0.65%)

ALXN

Alexion

$106.07

-0.37 (-0.35%)

AKCA

Akcea Therapeutics

$26.85

0.02 (0.07%)

RHHBY

Roche

TEVA

Teva

$17.27

-0.28 (-1.60%)

UBS

UBS

$16.78

-0.095 (-0.56%)

MDT

Medtronic

$79.47

0.12 (0.15%)

MCK

McKesson

$151.70

2.76 (1.85%)

NVTA

Invitae

$5.53

-0.15 (-2.64%)

IONS

Ionis Pharmaceuticals

$43.98

-1.35 (-2.98%)

IPXL

Impax

$19.25

-0.65 (-3.27%)

DNA

Bought by RHHBY

DGX

Quest Diagnostics

$101.17

1.42 (1.42%)

ESALY

Eisai

DEPO

Depomed

$6.66

-0.17 (-2.49%)

CPRX

Catalyst Pharmaceuticals

$2.64

0.04 (1.54%)

BSX

Boston Scientific

$29.44

1.01 (3.55%)

BMRN

BioMarin

$81.41

0.33 (0.41%)

MYL

Mylan

$38.93

-1.32 (-3.28%)

NBIX

Neurocrine

$78.13

-0.3 (-0.38%)

NVS

Novartis

$76.42

-0.58 (-0.75%)

PFE

Pfizer

$36.69

-0.36 (-0.97%)

RARX

RA Pharmaceuticals

$5.76

-0.2 (-3.36%)

SNY

Sanofi

$40.11

0.335 (0.84%)

SYK

Stryker

$165.44

0.77 (0.47%)

SUPN

Supernus

$47.30

0.55 (1.18%)

LLY

Eli Lilly

$81.17

1.08 (1.35%)

BAYRY

Bayer

AMGN

Amgen

$174.83

2.92 (1.70%)

ALNY

Alnylam

$94.35

-0.34 (-0.36%)

BIIB

Biogen

$269.47

7.45 (2.84%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Apr

  • 26

    Apr

  • 26

    Apr

  • 26

    Apr

  • 26

    Apr

  • 27

    Apr

  • 27

    Apr

  • 28

    Apr

  • 30

    Apr

  • 30

    Apr

  • 01

    May

  • 02

    May

  • 02

    May

  • 03

    May

  • 04

    May

  • 07

    May

  • 07

    May

  • 08

    May

  • 09

    May

  • 09

    May

  • 10

    May

  • 17

    May

  • 18

    May

  • 21

    May

  • 21

    May

  • 22

    May

  • 23

    May

  • 23

    May

  • 25

    May

  • 28

    May

  • 30

    May

  • 05

    Jun

  • 07

    Jun

  • 07

    Jun

  • 12

    Jun

  • 12

    Jun

  • 16

    Jun

  • 06

    Jul

  • 11

    Aug

  • 12

    Sep

  • 05

    Oct

  • 20

    Oct

  • 13

    Nov

  • 28

    Jan

SCPH

scPharmaceuticals

$9.92

-0.1 (-1.00%)

04:55
04/26/18
04/26
04:55
04/26/18
04:55
Conference/Events
scPharmaceuticals management to meet with Jefferies »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Apr

  • 23

    Jun

ALNA

Allena Pharmaceuticals

$14.77

0.845 (6.07%)

04:55
04/26/18
04/26
04:55
04/26/18
04:55
Conference/Events
Allena Pharmaceuticals management to meet with Jefferies »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Apr

RIO

Rio Tinto

$55.24

-0.44 (-0.79%)

04:55
04/26/18
04/26
04:55
04/26/18
04:55
Conference/Events
Rio Tinto management to meet with RBC Capital »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Apr

  • 27

    Apr

04:55
04/26/18
04/26
04:55
04/26/18
04:55
General news
Breaking General news story  »

Week of 4/22 Bloomberg…

SPNE

SeaSpine

$11.05

-0.11 (-0.99%)

04:55
04/26/18
04/26
04:55
04/26/18
04:55
Conference/Events
SeaSpine management to meet with Piper Jaffray »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Apr

  • 27

    Apr

  • 03

    May

PYPL

PayPal

$74.00

-1.29 (-1.71%)

04:55
04/26/18
04/26
04:55
04/26/18
04:55
Conference/Events
PayPal has a conference call hosted by JPMorgan »

JPMorgan Analyst Huang…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Apr

  • 22

    May

  • 23

    May

  • 12

    Jun

NFLX

Netflix

$305.73

-1.51 (-0.49%)

04:55
04/26/18
04/26
04:55
04/26/18
04:55
Conference/Events
Netflix management to meet with UBS »

Meeting to be held in New…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Apr

04:55
04/26/18
04/26
04:55
04/26/18
04:55
General news
Breaking General news story  »

3-Month Bill Announcement…

ADOM

Adomani

$0.71

-0.0401 (-5.35%)

, AEYE

AudioEye

04:55
04/26/18
04/26
04:55
04/26/18
04:55
Conference/Events
SNN to hold a conference »

Planet MicroCap Showcase…

ADOM

Adomani

$0.71

-0.0401 (-5.35%)

AEYE

AudioEye

AMBS

Amarantus Bioscience

AZRX

AzurRx BioPharma

$2.66

-0.23 (-7.96%)

CTHR

Charles & Colvard

$1.36

0.01 (0.74%)

DPW

DPW Holdings

$0.97

-0.0476 (-4.67%)

GMRE

Global Medical REIT

$7.81

-0.26 (-3.22%)

ISDR

Issuer Direct Corp.

$16.00

0.2 (1.27%)

ISR

IsoRay

$0.45

0.0046 (1.03%)

MNGA

Magnegas

$0.74

-0.0191 (-2.51%)

NEWT

Newtek Business Services

$17.78

-0.05 (-0.28%)

OMN

Omnova Solutions

$11.35

0.05 (0.44%)

PBIO

Pressure BioSciences

PFIE

Profire Energy

$3.94

0.27 (7.36%)

SGLB

Sigma Labs

$1.14

-0.02 (-1.72%)

SNYR

Synergy Strips

SRAX

Social Reality

$4.62

0.15 (3.36%)

SSFT

ScanSoft

VNRX

VolitionRx

$2.12

0.02 (0.95%)

XPLR

Xplore Technologies

$3.32

-0.04 (-1.19%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    May

  • 02

    May

  • 03

    May

  • 08

    May

  • 09

    May

  • 23

    May

  • 01

    Jun

  • 07

    Jun

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.